EMERYVILLE, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: XOMA), the biotech royalty aggregator, announced today ...
Analysts have recently evaluated XOMA Royalty and provided 12-month price targets. The average target is $119.2, accompanied ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback